Stockreport
Inimmune Strengthens Leadership Team Ahead of Phase 2 INI-2004 Allergic Rhinitis Data Readout [Yahoo! Finance]
Last general electric company earnings: 4/30 04:02 pm
Check Earnings Report
US:NYSE Investor Relations: ge.com/investor-relations/overview
Ryan McMillian named Head of Financial Strategy to support corporate strategy and long-term growth MISSOULA, Mont. March 5, 2026 /PRNewswire/ -- Inimmune Corporation, a clinical-stage biotechnology company developing next-generation immunotherapies, today announced the appointments of Ferdinand Massari, M.D., as Chief Medical Officer (CMO), and Ryan McMillian as Head of Financial Strategy. The appointments strengthen the leadership team as Inimmune advances its lead allergic rhinitis program, INI-2004, toward key milestones and planned expansion into allergic asthma and food allergy. Inimmune "Inimmune is entering an important phase of growth as we continue to advance our pipeline and broaden our capabilities," said David Burkhart, Ph.D., Chief Executive Officer of Inimmune Corporation. "As we look ahead to upcoming clinical milestones, Dr. Massari's deep clinical development expertise and Mr. McMillian's financial leadership position us to execute with focus and discipline as
[Read more]
| IMPACT SNAPSHOT | EVENT TIME: | GE | ||||
|---|---|---|---|---|---|---|
|
Last Price
|
Price Change
|
Price Change %
|
Volume Shares
|
Max Up
|
Max Down
|
Volume Ratio
%
|
Performance comparison
Updated
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| LAST PRICE | ||
| VWAP | ||
|
High:
|
MAX UP |
High:
|
|
Low:
|
MAX DOWN |
Low:
|
|
%
|
POST NEWS RANGE |
%
|
|
|
PRICE CHANGE |
|
|
|
PRICE CHANGE PERCENTAGE |
|
|
|
S&P 500 (SPX) |
|
|
%
|
VOLUME RATIO |
%
|
| VOLUME (SHARES) | ||
| TICKS | ||
|
|
AVG SHARES PER TRADE |
|
Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Be the first to know
Opt in for alerts from News Quantifed
Opt-in for
GE alerts
GE alerts
from News Quantified
Movers & Shakers
The biggest gainers and losers and WHY it moved
GE alerts
High impacting General Electric Company news events
Weekly update
A roundup of the hottest topics
GE
NEWS
NEWS
- GE Aerospace is Trading Near 52-Week High: Should You Buy the Stock? [Yahoo! Finance][Yahoo! Finance]
- GE Aerospace (GE) Is a Trending Stock: Facts to Know Before Betting on It [Yahoo! Finance][Yahoo! Finance]
- GE HealthCare to showcase AI and digital leadership at HIMSS 2026 [Yahoo! Finance][Yahoo! Finance]
- ??????????:???????????????·??EPC???2035????352??????????? [CNET News][CNET News]
- GE Aerospace Contracts Add Context To General Electric Valuation And Momentum [Yahoo! Finance][Yahoo! Finance]
- More
GE
SEC Filings
SEC Filings
- 3/4/26 - Form 4
- 3/4/26 - Form 4
- 3/4/26 - Form 4
- GE's page on the SEC website
- More